Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Drug Discovery Market Projected to Surpass USD 174.92 Billion by 2035 – SNS Insider

globenewswire.com
MRK Mentioned as a leading player in the European drug discovery market, specifically for its discoveries in Germany. The article focuses on market trends rather than company-specific performance. AZN Cited as a company with research centers in the UK and Sweden, contributing to Europe's mature drug discovery market. The article highlights market growth and technological adoption. SNY Identified as having research in France, contributing to the European drug discovery market. The overall sentiment of the article is about market expansion and technological integration. ROG Mentioned for its advanced large molecule discovery process in Switzerland, contributing to the European drug discovery market. The article's focus is on market trends and growth. NVS Cited for its advanced large molecule discovery process in Switzerland, contributing to the European drug discovery market. The article discusses market growth and technological advancements.

Global Drug Discovery Market Projected to Surpass USD 174.92 Billion by 2035 – SNS Insider Austin, United States, May 28, 2026 (GLOBE NEWSWIRE) -- “The Drug Discovery Market was valued at USD 71.95 billion in 2025 and is projected to surpass USD 174.92 billion by 2035, growing at a CAGR of 9.29% over 2026–2035, according to a new report by SNS Insider.”

The market is experiencing substantial growth as the pharmaceutical and biotechnology companies are rapidly adopting the artificial intelligence, high-throughput screening, genomics, and bioinformatics technologies for a faster therapeutic discovery and shorter drug development periods. Global drug development is also being transformed by increasing collaborations between pharma companies, contract research organizations (CROs) and AI technology providers.

Get a Sample Report of Drug Discovery Market Forecast @ https://www.snsinsider.com/sample-request/8522

AI Integration and Precision Medicine Accelerating Drug Discovery Innovation

Artificial intelligence has proven transformative in areas such as target identification, molecular modeling, candidate optimization and predictive analytics in drug discovery. Pharma firms are adopting AI-powered platforms in research in the early stages of the workflow, to optimize efficiency of research, reduce development costs and increase chances of success in clinical trials.

The industry is also witnessing increased investment in precision medicine and biologics research, particularly in oncology, immunology, gene therapy, and RNA-based therapeutics. The development of next-generation sequencing and biomarker analytics is driving improvements in personalized treatment development.

Moreover, biopharmaceutical companies will continue to extend partnerships and licensing agreements with biotechnology companies and CROs to diversify their research pipelines and obtain targeted discovery technologies.

Leading Market Players Listed in this Report are:

Segmentation Analysis:

By Process

Target identification & validation retained the largest process share at approximately 33.47% in 2025 due to the growing availability of human genetic association data from genome-wide association studies globally. Candidate Validation is the most rapidly growing segment within the processes category, showing a CAGR of 10.45% till 2035 due to the understanding of the pharmaceutical industry globally.

By Technology

High-throughput screening dominated the drug discovery market in 2025 with approximately 41.29% share due to its ability to rapidly evaluate millions of compounds against biological targets using automated robotics globally. The bioinformatics sector is expected to register the highest CAGR over 2035 owing to rapid advances in genomics and proteomics globally.

By Drug Type

Small molecules dominated the drug discovery market in 2025 with approximately 59.41% revenue share due to their oral bioavailability and cost-effective manufacturing globally. Biologics are projected to witness the fastest CAGR through 2035 driven by increasing development of monoclonal antibodies, vaccines, gene therapies, RNA therapeutics, and cell-based treatments.

By End User

The pharmaceutical and biotechnology firms dominated the drug discovery market during 2025 with a revenue share of around 52.56% owing to their high investment on research and development globally. Contract Research Organizations (CROs) are forecasted to have the highest CAGR till 2035, since pharmaceutical companies are outsourcing early stages of drug discovery globally.

Do you have any specific queries or need any customized research on Drug Discovery Market? Schedule a Call with Our Analyst Team @ https://www.snsinsider.com/enquiry/8522

Regional Insights:

North America accounts for a majority share of the world drug discovery market with approximately 41.27% revenue contribution in 2025, out of which the US holds around 83% share of North America’s drug discovery revenue. North America’s supremacy is owing to the fact that it has the world’s largest drug R&D expenditure and biotechnology venture capital funding.

The U.S. Drug Discovery Market was valued at approximately USD 24.53 billion in 2025 and is expected to reach approximately USD 62.14 billion by 2035, growing at a CAGR of 9.74%. The U.S. dominates the global market for drug discovery because of the unique blend of academia’s ability to conduct biological innovation, the research and development facilities at the large pharmaceutical companies, which provide the infrastructure necessary for biotech to bring drugs to market, and the CRO industry, which can provide advanced drug discovery science at reasonable prices.

The Europe Drug Discovery Market is estimated to be USD 20.76 Billion in 2025 and is projected to reach USD 47.84 Billion by 2035, growing at a CAGR of 8.69% during 2026–2035. Europe is a mature drug discovery market due to the advanced large molecule discovery process of Roche and Novartis in Switzerland, the research centers of AstraZeneca in the UK and Sweden, Sanofi’s research in France, and the discoveries of Bayer and Merck KGaA in Germany.

The Asia Pacific region has been observed to be the fastest-growing drug discovery market, expected to grow at a rate of 9.82% between 2026 and 2035, mainly due to the increasing development of pharmaceutical research infrastructure in China and India, rise of biotech industry in South Korea, Japan, Singapore, and Australia, and cost benefits offered by Asian CRO partners.

Recent Developments:

Exclusive Sections of the Report (The USPs):

Purchase Single User PDF of Drug Discovery Market Report (20% Discount) @ https://www.snsinsider.com/checkout/8522

Drug Discovery Market Report Scope

Related Market Reports

Artificial Intelligence in Drug Discovery Market Size, Share & Growth Report 2026

Large Molecule Drug Discovery Outsourcing Market Trends & Outlook 2026

Small Molecule Drug Discovery Outsourcing Market Analysis Report 2026

Drug Discovery Informatics Market Size & Demand Forecast 2026

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.